1. a b c d Goodrow EF, et al. Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrationsJ Nutr. (2006)
  2. a b c d Handelman GJ, et al. Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolkAm J Clin Nutr. (1999)
  3. a b c d Wenzel AJ, et al. A 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in womenJ Nutr. (2006)
  4. a b c d e f g h Hammond BR Jr, et al. Dietary modification of human macular pigment densityInvest Ophthalmol Vis Sci. (1997)
  5. a b Solomons NW, Bulux J. Plant sources of vitamin A and human nutrition revisited: recent evidence from developing countriesNutr Rev. (1994)
  6. ^ Stahl W, Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humansJ Nutr. (1992)
  7. a b c d e f g h i Chung HY, Rasmussen HM, Johnson EJ. Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in menJ Nutr. (2004)
  8. a b c d Vishwanathan R, et al. Consumption of 2 and 4 egg yolks/d for 5 wk increases macular pigment concentrations in older adults with low macular pigment taking cholesterol-lowering statinsAm J Clin Nutr. (2009)
  9. ^ Surai PF, et al. Designer egg evaluation in a controlled trialEur J Clin Nutr. (2000)
  10. a b Borel P, et al. Low and high responders to pharmacological doses of beta-carotene: proportion in the population, mechanisms involved and consequences on beta-carotene metabolismJ Lipid Res. (1998)
  11. ^ Johnson EJ, et al. Ingestion by men of a combined dose of beta-carotene and lycopene does not affect the absorption of beta-carotene but improves that of lycopeneJ Nutr. (1997)
  12. ^ Henderson CT, et al. Normal serum response to oral beta-carotene in humansJ Am Coll Nutr. (1989)
  13. ^ Ahmed SS, Lott MN, Marcus DM. The macular xanthophyllsSurv Ophthalmol. (2005)
  14. ^ Junghans A, Sies H, Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomesArch Biochem Biophys. (2001)
  15. ^ la Cour M, Kiilgaard JF, Nissen MH. Age-related macular degeneration: epidemiology and optimal treatmentDrugs Aging. (2002)
  16. ^ Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Arch Ophthalmol. (2001)
  17. ^ van Leeuwen R, et al. Dietary intake of antioxidants and risk of age-related macular degenerationJAMA. (2005)
  18. ^ Snellen EL, et al. Neovascular age-related macular degeneration and its relationship to antioxidant intakeActa Ophthalmol Scand. (2002)
  19. ^ [No authors listed. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study GroupArch Ophthalmol. (1992)
  20. ^ Beatty S, et al. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European populationInvest Ophthalmol Vis Sci. (2001)